SCHEMBL10054567

SCHEMBL10054567

Cc1ccccc1-c1cccc(-c2ccccc2C)c1-c1cc2sc3cc(-c4cc5sc6cc(-c7c(-c8ccccc8C)cccc7-c7ccccc7C)sc6c5s4)sc3c2s1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC9A1 P19634 2/20 0.35
▸ HPGD P15428 3/20 0.35
▸ MAPT P10636 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ USP2 O75604 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ NPC1 O15118 3/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ S1PR4 O95977 1/20 0.32
▸ S1PR5 Q9H228 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.31
▸ HTR7 P34969 1/20 0.31
▸ MYC P01106 1/20 0.31
▸ RAB9A P51151 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10054564 0.98 SLC9A1 (0.36) SLC9A1HPGDMAPTLMNATSHR
SCHEMBL10053984 0.86 HPGD (0.37) SLC9A1HPGDMAPTLMNATSHR
SCHEMBL10053973 0.84 HPGD (0.38) SLC9A1HPGDMAPTLMNATSHR
SCHEMBL19521963 0.82 ALDH1A1 (0.36) SLC9A1LMNATSHRNPC1HSD17B1
SCHEMBL14883353 0.80 APP (0.49) HPGDTSHRHTR7SMN1; SMN2ALDH1A1
SCHEMBL10053962 0.79 F9 (0.36) SLC9A1HPGDMAPTNPC1HSD17B1
SCHEMBL10054565 0.79 ESR1 (0.36) NPC1MEN1KMT2AHSD17B1HSD17B2
SCHEMBL14883351 0.78 APP (0.50) HPGDTSHRHTR7SMN1; SMN2ALDH1A1
SCHEMBL10053960 0.77 F9 (0.37) SLC9A1HPGDMAPTNPC1HSD17B1
SCHEMBL14225402 0.77 ESR1 (0.37) HPGDMAPTLMNAHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8982443-B2 Organic compound and electrochromic device including the same CANON KABUSHIKI KAISHA (JP) 2015-03-17 — — US disclosed
US-8982443-B2 Organic compound and electrochromic device including the same CANON KABUSHIKI KAISHA (JP) 2015-03-17 — — US disclosed
US-20130100517-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-04-25 — — US disclosed
US-20130100517-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-04-25 — — US disclosed
WO-2012002185-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2012-01-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130100517-A1 NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC DEVICE INCLUDING THE SAME CCNL2, DNMT3L, ARL1 SLC9A1 1820/4885HPGD 4658/4885MAPT 4005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback